Sherman Michael A.

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)43%6%(7%)0%
Purchase Success Rate1 of 21 of 21 of 20 of 20 of 2
Average Sale Return(51%)0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Endocyte, Inc.

Drugs » Drug Manufacturers - Major

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Chimerix, Inc.

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 423.41K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

BioSpecifics Technologies C...

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Mead Johnson Nutrition Comp...

Retail » Grocery Stores

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Werewolf Therapeutics, Inc.

Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--